Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:11 PM
Ignite Modification Date:
2025-12-24 @ 2:11 PM
NCT ID:
NCT05392595
Eligibility Criteria:
Inclusion Criteria:
* Male and Female, Age 30-65 years.
* BPPV diagnosis confirmed by the: 1. A specific history of vertigo/dizziness evoked by acceleration/deceleration. 2. Symptoms of vertigo during Dix Hallpike Test for Posterior Semicircular canal with or without accompanying nystagmus (objective or subjective BPPV)
* Patients diagnosed with BPPV for at least 6 months
Exclusion Criteria:
* Central nervous system (CNS) involvement,
* Meniere's disease,
* Severe eye disorder, labyrinthitis, vestibular neuritis,
* Any unstable medical condition (e.g severe hypertension or unstable cardiac diagnosis).
* Any Cervical pathology.
* Orthopedic or neurologic diagnoses including sensory loss (e.g diabetes) that might affect postural control and have an impact on functional mobility.
Long-term use of benzodiazepines (more than 20 years).
* Cognitive decline or reduced cultural level that prevents the patient from understanding the assessment, vestibular rehabilitation exercises, and granting informed consent.
* Other Balance Disorders
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
30 Years
Maximum Age:
65 Years
Study:
NCT05392595
Study Brief:
Protocol Section:
NCT05392595